APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Asthma Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173967760320 December 2025183 pages

Choose your research edition.

Industry ResearchAsthma Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Asthma Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Asthma Drugs include Teva Pharmaceutical, Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, AstraZeneca, Vectura Group and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Asthma Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Asthma Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Asthma Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Asthma Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Asthma Drugs Segment by Company

Teva Pharmaceutical

Novartis

Merck

Roche

Pfizer

GlaxoSmithKline

AstraZeneca

Vectura Group

Boehringer Ingelheim

Asthma Drugs Segment by Type

Quick-relief Medications (Rescue Medications)

Medications for Allergy-induced Asthma

Asthma Drugs Segment by Application

Allergic Asthma

Non-Allergic Asthma

Asthma Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Asthma Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Asthma Drugs Industry Trends Table 2. Asthma Drugs Industry Drivers Table 3. Asthma Drugs Industry Opportunities and Challenges Table 4. Asthma Drugs Industry Restraints Table 5. Global Asthma Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Asthma Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Asthma Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Asthma Drugs Sales Market Share by Manufacturers Table 9. Global Asthma Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Asthma Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Asthma Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Asthma Drugs Manufacturers, Product Type & Application Table 13. Global Asthma Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Asthma Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Quick-relief Medications (Rescue Medications) Table 17. Major Manufacturers of Medications for Allergy-induced Asthma Table 18. Global Asthma Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Asthma Drugs Sales Market Share by Type (2021-2026) Table 22. Global Asthma Drugs Sales Market Share by Type (2027-2032) Table 23. Global Asthma Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Asthma Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Asthma Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Asthma Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Asthma Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Allergic Asthma Table 29. Major Manufacturers of Non-Allergic Asthma Table 30. Global Asthma Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 32. Global Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 33. Global Asthma Drugs Sales Market Share by Application (2021-2026) Table 34. Global Asthma Drugs Sales Market Share by Application (2027-2032) Table 35. Global Asthma Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Asthma Drugs Revenue by Application (2021-2026) & (K Units) Table 37. Global Asthma Drugs Revenue by Application (2027-2032) & (K Units) Table 38. Global Asthma Drugs Revenue Market Share by Application (2021-2026) Table 39. Global Asthma Drugs Revenue Market Share by Application (2027-2032) Table 40. Global Asthma Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Asthma Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Asthma Drugs Sales Market Share by Region (2021-2026) Table 43. Global Asthma Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Asthma Drugs Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Asthma Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 47. North America Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 48. Europe Asthma Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 50. Europe Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Asthma Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Asthma Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 57. Global Asthma Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Asthma Drugs Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Asthma Drugs Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Asthma Drugs Revenue Market Share by Region (2021-2026) Table 61. Global Asthma Drugs Revenue Market Share by Region (2027-2032) Table 62. Teva Pharmaceutical Company Information Table 63. Teva Pharmaceutical Business Overview Table 64. Teva Pharmaceutical Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Pharmaceutical Asthma Drugs Product Portfolio Table 66. Teva Pharmaceutical Recent Development Table 67. Novartis Company Information Table 68. Novartis Business Overview Table 69. Novartis Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novartis Asthma Drugs Product Portfolio Table 71. Novartis Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck Asthma Drugs Product Portfolio Table 76. Merck Recent Development Table 77. Roche Company Information Table 78. Roche Business Overview Table 79. Roche Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Roche Asthma Drugs Product Portfolio Table 81. Roche Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pfizer Asthma Drugs Product Portfolio Table 86. Pfizer Recent Development Table 87. GlaxoSmithKline Company Information Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline Asthma Drugs Product Portfolio Table 91. GlaxoSmithKline Recent Development Table 92. AstraZeneca Company Information Table 93. AstraZeneca Business Overview Table 94. AstraZeneca Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. AstraZeneca Asthma Drugs Product Portfolio Table 96. AstraZeneca Recent Development Table 97. Vectura Group Company Information Table 98. Vectura Group Business Overview Table 99. Vectura Group Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Vectura Group Asthma Drugs Product Portfolio Table 101. Vectura Group Recent Development Table 102. Boehringer Ingelheim Company Information Table 103. Boehringer Ingelheim Business Overview Table 104. Boehringer Ingelheim Asthma Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Boehringer Ingelheim Asthma Drugs Product Portfolio Table 106. Boehringer Ingelheim Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Asthma Drugs Distributors List Table 110. Asthma Drugs Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Asthma Drugs Product Image Figure 2. Global Asthma Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Asthma Drugs Sales (2021-2032) & (K Units) Figure 5. Global Asthma Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Asthma Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Quick-relief Medications (Rescue Medications) Image Figure 9. Medications for Allergy-induced Asthma Image Figure 10. Global Asthma Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Asthma Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Asthma Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Asthma Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Asthma Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Asthma Drugs Revenue Market Share by Type (2021-2032) Figure 16. Allergic Asthma Image Figure 17. Non-Allergic Asthma Image Figure 18. Global Asthma Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Asthma Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Asthma Drugs Sales Market Share by Application (2021-2032) Figure 21. Global Asthma Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Asthma Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Asthma Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Asthma Drugs Sales Market Share by Country (2021-2032) Figure 26. U.S. Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Asthma Drugs Sales Market Share by Country (2021-2032) Figure 31. Germany Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Asthma Drugs Sales Market Share by Country (2021-2032) Figure 38. China Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Asthma Drugs Sales Market Share by Country (2021-2032) Figure 46. Brazil Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Asthma Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Asthma Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Asthma Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Asthma Drugs Revenue (2021-2032) & (US$ Million) Figure 57. North America Asthma Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Asthma Drugs Revenue (2021-2032) & (US$ Million) Figure 59. Europe Asthma Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Asthma Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Asthma Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Asthma Drugs Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Asthma Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asthma Drugs Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Asthma Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Quick-relief Medications (Rescue Medications)
  • Medications for Allergy-induced Asthma
Applications
  • Allergic Asthma
  • Non-Allergic Asthma
Companies covered
  • Teva Pharmaceutical
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Vectura Group
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Asthma Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Asthma Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Asthma Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Asthma Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Asthma Drugs Market Dynamics
  1. 2.1 Asthma Drugs Industry Trends
  2. 2.2 Asthma Drugs Industry Drivers
  3. 2.3 Asthma Drugs Industry Opportunities and Challenges
  4. 2.4 Asthma Drugs Industry Restraints
3 Asthma Drugs Market by Manufacturers
  1. 3.1 Global Asthma Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Asthma Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Asthma Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Asthma Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Asthma Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Asthma Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Asthma Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Asthma Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Asthma Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Asthma Drugs Tier 1, Tier 2, and Tier 3
4 Asthma Drugs Market by Type
  1. 4.1 Asthma Drugs Type Introduction
  2. 4.1.1 Quick-relief Medications (Rescue Medications)
  3. 4.1.2 Medications for Allergy-induced Asthma
  4. 4.2 Global Asthma Drugs Sales by Type
  5. 4.2.1 Global Asthma Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Asthma Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Asthma Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Asthma Drugs Revenue by Type
  9. 4.3.1 Global Asthma Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Asthma Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Asthma Drugs Revenue Market Share by Type (2021-2032)
5 Asthma Drugs Market by Application
  1. 5.1 Asthma Drugs Application Introduction
  2. 5.1.1 Allergic Asthma
  3. 5.1.2 Non-Allergic Asthma
  4. 5.2 Global Asthma Drugs Sales by Application
  5. 5.2.1 Global Asthma Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Asthma Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Asthma Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Asthma Drugs Revenue by Application
  9. 5.3.1 Global Asthma Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Asthma Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Asthma Drugs Revenue Market Share by Application (2021-2032)
6 Global Asthma Drugs Sales by Region
  1. 6.1 Global Asthma Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Asthma Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Asthma Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Asthma Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Asthma Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Asthma Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Asthma Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Asthma Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Asthma Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Asthma Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Asthma Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Asthma Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Asthma Drugs Revenue by Region
  1. 7.1 Global Asthma Drugs Revenue by Region
  2. 7.1.1 Global Asthma Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Asthma Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Asthma Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Asthma Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Asthma Drugs Revenue (2021-2032)
  8. 7.2.2 North America Asthma Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Asthma Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Asthma Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Asthma Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Asthma Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Asthma Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Asthma Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Asthma Drugs Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Asthma Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Asthma Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Asthma Drugs Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Asthma Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Asthma Drugs Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Asthma Drugs Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Vectura Group
  44. 8.8.1 Vectura Group Company Information
  45. 8.8.2 Vectura Group Business Overview
  46. 8.8.3 Vectura Group Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vectura Group Asthma Drugs Product Portfolio
  48. 8.8.5 Vectura Group Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Asthma Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Asthma Drugs Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Asthma Drugs Value Chain Analysis
  2. 9.1.1 Asthma Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Asthma Drugs Production Mode & Process
  6. 9.2 Asthma Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Asthma Drugs Distributors
  9. 9.2.3 Asthma Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst